Web Analytics
ADMA (NASDAQ) Stock Analysis | ADMA BIOLOGICS INC – Deepscope
MARKET

Select Market Data Region

ADMA — ADMA BIOLOGICS INC (Healthcare >> Biotechnology)

ADMA FAQ

What is ADMA's P/E ratio?

ADMA BIOLOGICS INC (ADMA) currently trades at a P/E ratio of 11.19.

What is ADMA's ROE?

ADMA BIOLOGICS INC reports a Return on Equity (ROE) of 42.36%.

What is ADMA's dividend yield?

ADMA BIOLOGICS INC offers a dividend yield of 0.00%.

What is ADMA's Deepscope Quality Score?

Deepscope rates ADMA's overall financial quality at 54 out of 100, based on profitability, growth, debt and earnings stability.

Is now a good time to buy ADMA?

Deepscope's AI Timing Score for ADMA is 26 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.

Which sector does ADMA belong to?

ADMA BIOLOGICS INC is classified under the Healthcare >> Biotechnology sector on the NASDAQ exchange.

Stock Check   *Daily update data at 9:30 AM*
(Price: 2026-06-03 | FS: 2026-03-31)

ADMA

ADMA BIOLOGICS INC
USD 7.76
0.16 (2.11%) Day Change
11.19
P/E
0.51
D/E
42.4%
ROE
24.9%
ROA
0.00%
Div Yield
-0.04
PEG
USD 7.76
Price
0.16 (2.11%)
Day Change
NEWS SCORE: 91

ADMA, the overall quality is not quite good ( Quality = 54) and the timing to buy is ...(Sign In to See)...

54

QUALITY

Signal
UNDERPERFORM
Signal Description
Company financial health is Not Good
Reason
Acceleration of ROE growth rate is below our criteria.
Negative growth of ROE in the last year.
ROA is too relatively low compare to ROE
Acceleration of ROA growth rate is below our criteria.
Growth of ROA was below our criteria in the last year.
Acceleration of net profit margin growth rate is below our criteria

88 Sign in

TIMING

Signal
OUTPERFORM
Signal Descri...
Good
Reason
Lorem ipsum dolor sit amet
Sign in to see timing analysis
Unlock timing signals and detailed reasons
Sign in free

In details, quality factors are not quite good , financial health is not quite good , and ability to make profit is good , ...

Quality Factors 52%
X
X
X
X
  In Recommendations? Not in any sections
  Select Rate 0.00 From 30 days period
  Watch Rate 0.00 From 30 days period
  News Score 91
  Magic Formula Rank by ROA
224
  Magic Formula Rank by ROE
224
  Magic Formula Rank by ROIC
205
  Price 7.76
  PBV / Sector
4.74 / 4.48
  Earning Per Share 0.69
  PE / Sector
11.19 / 16.68
GOOD
  PEG or PE/Growth / Sector
-0.04 / 0.53
  Average 1M Daily Value
50.09 M
  Average 1W Daily Value
21.56 M
GREAT
Timing Factors 42%
  MACD
  MACD Signal
  MACD Divergence
  RSI
  Stochastic Oscillator K
  Stochastic Oscillator D
  ADX
  Avg 5 day Timing Score
Financial Health 50%
X
X
X
X
  DE / Sector
  DE Average / Sector
  DE Change Average (%) / Sector
  Current Ratio / Sector
  Current Ratio Average / Sector
  Current Ratio Change Average (%) / Sector
  Quick Ratio / Sector
  Quick Ratio Average / Sector
  Quick Ratio Change Average (%) / Sector
  FCF/Share / Sector
  FCF/Share Average / Sector
  FCF/Share Change Average (%) / Sector
Ability to Make Profit 72%
X
X
X
X
X
X
X
  GPM (%) / Sector
  GPM Average (%) / Sector
  GPM Change Average (%) / Sector
  OPM (%) / Sector
  OPM Average (%) / Sector
  OPM Change Average (%) / Sector
  NPM (%) / Sector
32.43 / 450.37
GREAT
  NPM Average (%) / Sector
10.78 / -1,506.30
GOOD
  NPM Change Average (%) / Sector
-155.88 / 4,941.44
  Asset Turnover / Sector
  Asset Turnover Average / Sector
  Asset Turnover Change Average (%) / Sector
  ROA (%) / Sector
24.86 / 30.83
GOOD
  ROA Average (%) / Sector
12.27 / -347.12
  ROA Change Average (%) / Sector
-165.59 / 5,126.35
  ROE (%) / Sector
42.36 / -3.04
GREAT
  ROE Average (%) / Sector
13.11 / 40.76
  ROE Change Average (%) / Sector
-107.76 / 2,110.63
  ROIC (%) / Sector
  ROIC Average (%) / Sector
  ROIC Change Average (%) / Sector
Return to Investors 4%
X
  Dividend (%) / Sector
N/A / 0.05
  Dividend Average (%) / Sector
N/A / 16.49
  Dividend Change Average (%) / Sector
N/A / 5.25
Registration Details
X
  Analyze Date 2026-06-04 09:23:58
  Symbol ADMA
  Name ADMA BIOLOGICS INC
  Sector Healthcare >> Biotechnology
  Market NASDAQ
  Listed Shares 231.77 M
  Par Value N/A
  Calculated From Quarter
  Sign N/A
  Market Cap (M.USD) / Sector Average 1,849.55 / 8,483.11
News, Concensus, ...
  Estimation Consensus See at WSJ.com
  Full details See at WSJ.com
  Chart See in Chart feature
  News See at Yahoo Finance

Address: 465 State Route 17, Ramsey, NJ, United States, 07446

Phone: 201 478 5552

Website: https://www.admabiologics.com

Employees: 640

Sector: Healthcare >> Biotechnology

Description: ADMA Biologics, Inc., a biopharmaceutical company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. The company operates through ADMA BioManufacturing and Plasma Collection Centers segments. The company offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primary humoral immunodeficiency (PI); ASCENIV, an IVIG product for the treatment of PI; and Nabi-HB, a human polyclonal antibody product for the treatment of acute exposure to blood containing Hepatitis B surface antigen and other listed exposures to Hepatitis B. It also develops a pipeline of plasma-derived therapeutics comprising products related to the methods of treatment and prevention of S. pneumonia infection for an immunoglobulin. In addition, the company operates source plasma collection facilities. The company sells its products through independent distributors, drug wholesalers, specialty pharmacies, and other alternate site providers. ADMA Biologics, Inc. was incorporated in 2004 and is headquartered in Ramsey, New Jersey.

ME vs SECTOR Healthcare >> Biotechnology

ADMA (ME)
Sector Peers
Bubble size = Market Cap

Click a bubble to view stock details  ·  Bubble size represents market capitalization share

News

Smart picks. Just WOW stocks/funds/ETFs. No noise like other tools.
ADMA
ADMA
USD 7.76 (2.11%)
+ Watch + Port Chart